News Medical on MSN3d
Insilico Medicine announces developmental candidate benchmarks and timelines for novel therapeutics discovered using generative AIInsilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...
Selkirk’s ClinFAST™ rapid fill-finish service supports small-batch projects that larger contract manufacturing organizations ...
Q1 2025 Management View CEO Christopher Missling highlighted key updates on the Alzheimer's treatment, blarcamesine. He emphasized the potential of the drug to offer "a scalable treatment alternative ...
Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
GlobalData on MSN1d
Selkirk Pharma introduces new service for rapid delivery of trial suppliesSelkirk Pharma has introduced a paradigm-shifting service, ClinFAST, for ensuring rapid small-volume clinical study materials ...
Blueprint Medicines (BPMC) sees strong AYVAKIT growth, 2025 revenue guidance at $680M-$710M. Discover insights on their market expansion & $2B 2030 vision.
Cutting-Edge Cardiac Research: Novoheart’s CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback